LANSING, MI--(Marketwire - July 05, 2011) - Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced the completion of its first round of zinc finger micro-insertions.
“We are very excited to be performing these genetic engineering feats so soon after signing the agreement for their use with Sigma-Aldrich,” said CEO and company founder, Kim K. Thompson. “The immediate results from this first round of generic insertion are truly encouraging, as we observed a high hatch rate within a few days of employing the new technology.”
In April, Kraig entered into an agreement with Sigma-Aldrich to use Sigma’s powerful zinc finger technology to accelerate Kraig’s scientific research and product development. The zinc fingers are an effective genetic engineering technology that the Company is using to create the next generation of biomaterials, including recombinant spider silks, for the textile and technical textile markets.
“The company has very high expectations for these newly hatched silkworms and we are watching their development closely,” Thompson continued. “As of yet, the caterpillars are far too small for us to determine whether we hit our genetic target. So far, the technology is performing as anticipated and, even as we monitor the development of these silkworms, we are preparing for the next round of micro-insertions.”
About Kraig Biocraft Laboratories
Kraig Biocraft Laboratories is a fully reporting biotechnology company that recently achieved a series of scientific breakthroughs, with implications for the global textile industry. For further information, please visit www.KraigLabs.com.
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “develops,” “researching,” “research,” “potential,” “could” or other words or phrases of similar import. Similarly, statements in this release that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company’s financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
Contact:
Ben Hansel
(720) 288-8495
